• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
LDX
Click for more information
2.94% 3.3¢

LUMOS DIAGNOSTICS HOLDINGS LIMITED - Charts / Financials

Market Cap $18.57M  ! watchlist Created with Sketch. Add to my watchlist

Lumos Diagnostics Holdings Ltd is an Australia-based company, which specializes in... Lumos Diagnostics Holdings Ltd is an Australia-based company, which specializes in point-of-care (POC) diagnostic test technology to help healthcare professionals diagnose and manage medical conditions. The Company offers customized assay development and manufacturing services for POC tests and digital reader platforms. It also directly develops, manufactures, and commercializes, Lumos-branded POC tests that target infectious and inflammatory diseases. The Company’s products include FEBRIDX, COVIDX, and ViraDx. FebriDx is a point-of-care test which can be used to detect and aid in differentiating bacterial from viral acute respiratory infections. ViraDx is a point-of-care, three-in-one COVID-19/Flu A/Flu B rapid antigen test. Its services include assay development, reader development, cloud and data, and manufacturing. It manages the full development program for point-of-care (POC) assays, from sourcing and/or generation of reagents, right through to verification and validation.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits
refresh Created with Sketch. REFRESH
Last update - 15.53pm 21/11/2024 (20 minute delay) ?
Day
Open 3.6¢   Day High 3.6¢   Day Low 3.2¢
Daily Volume 4525491
Bids   Sellers
Number Price Volume   Number Price Volume
1 3.3¢ 1015324   7 3.4¢ 1275725

Directors & Senior Management

Mr. Samuel Lanyon Executive Chairman of the Board
Mr. Doug Ward Chief Executive Officer, Managing Director, Director
Mr. Barrie Lambert Chief Financial Officer
Mr. Paul Kase Senior Vice President of Commercial Operations
MS. Sacha Dopheide Chief Technology Officer
Mr. Kepa Oyarbide Vice President Technology Transfer and Pilot Manufacturing
Ms. Annie Bell Senior Director of Medical Affairs
Ms. Sarah Glubka Senior Director of Human Resources
Ms. Sue Hibbeln Senior Director of Regulatory Affairs
Ms. Melanie Jaye Leydin Company Secretary
Mr. Lawrence Mehren Non-Executive Deputy Chairman of the Board
Ms. Bronwyn Le Grice Non-Executive Director
Ms. Catherine Anne Robson Non-Executive Director

Data source: Refinitiv

(20min delay)
Last
3.3¢ 		Change
-0.001(2.94%) 		Mkt cap ! $18.57M
Open High Low Value Volume
3.6¢ 3.6¢ 3.2¢ $153.7K 4.525M

Buyers (Bids)

No. Vol. Price($)
1 1015324 3.3¢
 

Sellers (Offers)

Price($) Vol. No.
3.4¢ 1275725 7
View Market Depth
Last trade - 16.10pm 21/11/2024 (20 minute delay) ?
Last
3.3¢ 		  Change
-0.001 ( 2.94 %)
Open High Low Volume
3.6¢ 3.6¢ 3.2¢ 1788894
Last updated 15.53pm 21/11/2024 ?

Top Stories

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

Who the MinRes Board has decided to move on faster may or may not be amusing, depending on how much you've lost.
To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels Put simply: if 3D Printing is a gold rush, Amaero is selling shovels. Or maybe it's more like sneakers in an arms race.
Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects Pan Asia Metals has scored $35 million from a New York private equity firm at the same time as the company's big rebrand push begins.
Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing Bigtincan Holdings has fielded an offer from Investcorp. But if you think it's underwhelming – consider Wall Street volumes.
Alcidion inks deal with Vic health provider Peninsula for use of Miya Precision tech Alcidion Group Ltd has signed a contract worth $3.7M to enable use of its Miya Precision platform by users of Peninsula Health entities
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.